Global In-Vitro ADME Services Market By Type (Solution Properties, Drug Absorption & Transport, Drug Metabolism, Drug – Drug Interactions) - Growth, Share, Opportunities, Competitive Analysis And Forecast 2016 – 2023

ADME is the abbreviation for absorption, distribution, metabolism, and elimination, a pharmacology and pharmacokinetics term that describes the disposition of a drug or compound inside the human body. ADME comprises a set of four processes that develop the performance of a drug on human tissue, and ADME toxicology testing is applied for the development of a new drug.

With the advancement of technology and the reliability of ADME testing due to its accurate and predictable results, its usage in drug development and initial screening for novel products has increased.

The report titled "Global In-Vitro ADME Services Market: Growth, Share, Opportunities, and Competitive Analysis, 2016–2023" offers strategic insights into the overall In-Vitro ADME Services market, along with the market size and estimates for the duration of 2016 to 2023.

The said research study covers an in-depth analysis of multiple market segments based on the type of service and different geographical regions. The service type segment studied for analyzing the overall in-vitro ADME services market is majorly segmented into Solution Properties, Drug Absorption and Transport, Drug Metabolism, and Drug-Drug Interaction.

The report also includes competitive profiling of the leading players in the in-vitro ADME services market, as well as attractive investment propositions and market positioning of key manufacturers, to assist strategic decision-makers.Other in-depth analysis provided in the report includes:

Geographically, the global in-vitro ADME services market is studied for the following regional markets:

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Rest of Europe
• Asia-Pacific
• China
• Japan
• Rest of Asia Pacific
• Latin America
• Mexico
• Brazil
• Rest of LATAM
• Middle East and Africa

The market size and forecast for these regional and country-level markets are presented in this study for the period 2013–2023. Market growth rates for the forecast period 2016–2023 are also included in this report, considering 2015 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global in-vitro ADME services market.

Tools such as key player market positioning and appealing investment propositions provide readers with insights into the competitive landscape of the global in-vitro ADME services market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global in-vitro ADME services market. In-depth competitive environment analysis and historical years (2013 and 2014) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global in-vitro ADME services market, offering market size and estimates for the period from 2016 to 2023, keeping in mind the above-mentioned factors.

Based on the type of product, the global in-vitro ADME services market is segmented as follows:

• Solution Properties
• drug absorption and transport
• Drug Metabolism
• drug-drug interaction

In 2015, drug absorption and transport were observed as the largest segment, followed by drug metabolism, due to factors such as cost-efficiency, rising demand for novel technologies, and increasing research and development activities in the field of pharmaceutical and biopharmaceutical industries.

Drug absorption and transport mainly involve processes such as parallel artificial membrane permeability assay (PAMPA) permeability screening, Caco-2 permeability screening, MDCK permeability, and a transporter assay platform. Drug absorption and transport are followed by drug metabolism, mainly due to the presence of high market demand, increasing surveillance by regulatory bodies, and rising research and development activities in the field of medicine.

Service providers operating in drug metabolism services help to identify the metabolic pathways, potential interactions, and routes of elimination of compounds at an early stage. The pharmaceutical industry has been evolving in recent years, along with several CROs and biotech companies conducting drug discovery and development programs and services in Asia-Pacific.

It was also observed that a broad and vital technology platform bridges efficacy and safety, and drug metabolism and pharmacokinetics have become a mature discovery function to optimize ADME properties in drug design and screening and dramatically mitigate attrition rates over the last two decades.

For the purpose of this study, the global in-vitro ADME services market is categorized into:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)

The global in-vitro ADME market is bifurcated into four regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East. The Europe region dominates the global in-vitro ADME services market, accounting for the majority of the market. Increased academic research and development in drug discovery and drug metabolism are attributed to Europe's growth.

Moreover, most of the research activities are carried out in the region and not outsourced to other regions. Asia-Pacific's in-vitro ADME services market is the fastest-growing market in the world.

The market is likely to grow with the increase in drug discovery efforts in the pharmaceutical industry. It is expected that the in-vitro ADME services market in Latin America, the Middle East, and Africa will witness rapid growth in the given period of forecast.

Frequently Asked Question: